Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Dako Diagnostics , Ltd. — Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

216 daysmedian FDA review time
707 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K981226IMAGEARAINFLUENZA VIRUS GROUP (TYPES 1,2 AND 3) TEST AND IMADako Diagnostics , Ltd.1998-09-281880
K973954IMAGEN RESPIRATORY SCREENDako Diagnostics , Ltd.1997-12-22740
K962037IMAGEN RESPIRATORY SCREENDako Diagnostics , Ltd.1996-12-262160
K940564IDEIA(TM) CHLAMYDIA BLOCKING REAGENTS, MODIFICATIONDako Diagnostics , Ltd.1996-01-117070
K943557IMAGENDako Diagnostics , Ltd.1995-01-091710
K932384IDEIA(TM) ROTAVIRUSDako Diagnostics , Ltd.1993-12-272240

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda